Global Dendritic Cell Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Page: 119

Published Date: 13 Jan 2025

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Dendritic Cell Vaccine market size was valued at US$ 70.9 million in 2024 and is forecast to a readjusted size of USD 87.1 million by 2031 with a CAGR of 3.0% during review period.

Dendritic cells (DCs) have several characteristics that make them an ideal vehicle for tumor vaccines, and with the first US FDA-approved DC-based vaccine in use for the treatment of prostate cancer, this technology has become a promising new therapeutic option.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report is a detailed and comprehensive analysis for global Dendritic Cell Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global Dendritic Cell Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Dendritic Cell Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Dendritic Cell Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Dendritic Cell Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Dendritic Cell Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Dendritic Cell Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 3M, Activarti, Argos Therapeutics, Batavia Bioservices, Bellicum Pharmaceuticals, Creagene, DanDrit Biotech, DCPrime, Sanpower Corporation (Dendreon Corporation), Elios Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Dendritic Cell Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Non-Targeted
    Target

Market segment by Application
    Covid-19
    Cancer
    Others

Major players covered
    3M
    Activarti
    Argos Therapeutics
    Batavia Bioservices
    Bellicum Pharmaceuticals
    Creagene
    DanDrit Biotech
    DCPrime
    Sanpower Corporation (Dendreon Corporation)
    Elios Therapeutics
    ImmunoCellular Therapeutics
    Immunicum
    Kiromic
    Medigene
    Merck & Co.

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dendritic Cell Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Dendritic Cell Vaccine, with price, sales quantity, revenue, and global market share of Dendritic Cell Vaccine from 2020 to 2025.
Chapter 3, the Dendritic Cell Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dendritic Cell Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Dendritic Cell Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Dendritic Cell Vaccine.
Chapter 14 and 15, to describe Dendritic Cell Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Dendritic Cell Vaccine Consumption Value by Type: 2020 Versus 2024 Versus 2031
        1.3.2 Non-Targeted
        1.3.3 Target
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Dendritic Cell Vaccine Consumption Value by Application: 2020 Versus 2024 Versus 2031
        1.4.2 Covid-19
        1.4.3 Cancer
        1.4.4 Others
    1.5 Global Dendritic Cell Vaccine Market Size & Forecast
        1.5.1 Global Dendritic Cell Vaccine Consumption Value (2020 & 2024 & 2031)
        1.5.2 Global Dendritic Cell Vaccine Sales Quantity (2020-2031)
        1.5.3 Global Dendritic Cell Vaccine Average Price (2020-2031)

2 Manufacturers Profiles
    2.1 3M
        2.1.1 3M Details
        2.1.2 3M Major Business
        2.1.3 3M Dendritic Cell Vaccine Product and Services
        2.1.4 3M Dendritic Cell Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.1.5 3M Recent Developments/Updates
    2.2 Activarti
        2.2.1 Activarti Details
        2.2.2 Activarti Major Business
        2.2.3 Activarti Dendritic Cell Vaccine Product and Services
        2.2.4 Activarti Dendritic Cell Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.2.5 Activarti Recent Developments/Updates
    2.3 Argos Therapeutics
        2.3.1 Argos Therapeutics Details
        2.3.2 Argos Therapeutics Major Business
        2.3.3 Argos Therapeutics Dendritic Cell Vaccine Product and Services
        2.3.4 Argos Therapeutics Dendritic Cell Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.3.5 Argos Therapeutics Recent Developments/Updates
    2.4 Batavia Bioservices
        2.4.1 Batavia Bioservices Details
        2.4.2 Batavia Bioservices Major Business
        2.4.3 Batavia Bioservices Dendritic Cell Vaccine Product and Services
        2.4.4 Batavia Bioservices Dendritic Cell Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.4.5 Batavia Bioservices Recent Developments/Updates
    2.5 Bellicum Pharmaceuticals
        2.5.1 Bellicum Pharmaceuticals Details
        2.5.2 Bellicum Pharmaceuticals Major Business
        2.5.3 Bellicum Pharmaceuticals Dendritic Cell Vaccine Product and Services
        2.5.4 Bellicum Pharmaceuticals Dendritic Cell Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.5.5 Bellicum Pharmaceuticals Recent Developments/Updates
    2.6 Creagene
        2.6.1 Creagene Details
        2.6.2 Creagene Major Business
        2.6.3 Creagene Dendritic Cell Vaccine Product and Services
        2.6.4 Creagene Dendritic Cell Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.6.5 Creagene Recent Developments/Updates
    2.7 DanDrit Biotech
        2.7.1 DanDrit Biotech Details
        2.7.2 DanDrit Biotech Major Business
        2.7.3 DanDrit Biotech Dendritic Cell Vaccine Product and Services
        2.7.4 DanDrit Biotech Dendritic Cell Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.7.5 DanDrit Biotech Recent Developments/Updates
    2.8 DCPrime
        2.8.1 DCPrime Details
        2.8.2 DCPrime Major Business
        2.8.3 DCPrime Dendritic Cell Vaccine Product and Services
        2.8.4 DCPrime Dendritic Cell Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.8.5 DCPrime Recent Developments/Updates
    2.9 Sanpower Corporation (Dendreon Corporation)
        2.9.1 Sanpower Corporation (Dendreon Corporation) Details
        2.9.2 Sanpower Corporation (Dendreon Corporation) Major Business
        2.9.3 Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Product and Services
        2.9.4 Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.9.5 Sanpower Corporation (Dendreon Corporation) Recent Developments/Updates
    2.10 Elios Therapeutics
        2.10.1 Elios Therapeutics Details
        2.10.2 Elios Therapeutics Major Business
        2.10.3 Elios Therapeutics Dendritic Cell Vaccine Product and Services
        2.10.4 Elios Therapeutics Dendritic Cell Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.10.5 Elios Therapeutics Recent Developments/Updates
    2.11 ImmunoCellular Therapeutics
        2.11.1 ImmunoCellular Therapeutics Details
        2.11.2 ImmunoCellular Therapeutics Major Business
        2.11.3 ImmunoCellular Therapeutics Dendritic Cell Vaccine Product and Services
        2.11.4 ImmunoCellular Therapeutics Dendritic Cell Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.11.5 ImmunoCellular Therapeutics Recent Developments/Updates
    2.12 Immunicum
        2.12.1 Immunicum Details
        2.12.2 Immunicum Major Business
        2.12.3 Immunicum Dendritic Cell Vaccine Product and Services
        2.12.4 Immunicum Dendritic Cell Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.12.5 Immunicum Recent Developments/Updates
    2.13 Kiromic
        2.13.1 Kiromic Details
        2.13.2 Kiromic Major Business
        2.13.3 Kiromic Dendritic Cell Vaccine Product and Services
        2.13.4 Kiromic Dendritic Cell Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.13.5 Kiromic Recent Developments/Updates
    2.14 Medigene
        2.14.1 Medigene Details
        2.14.2 Medigene Major Business
        2.14.3 Medigene Dendritic Cell Vaccine Product and Services
        2.14.4 Medigene Dendritic Cell Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.14.5 Medigene Recent Developments/Updates
    2.15 Merck & Co.
        2.15.1 Merck & Co. Details
        2.15.2 Merck & Co. Major Business
        2.15.3 Merck & Co. Dendritic Cell Vaccine Product and Services
        2.15.4 Merck & Co. Dendritic Cell Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.15.5 Merck & Co. Recent Developments/Updates

3 Competitive Environment: Dendritic Cell Vaccine by Manufacturer
    3.1 Global Dendritic Cell Vaccine Sales Quantity by Manufacturer (2020-2025)
    3.2 Global Dendritic Cell Vaccine Revenue by Manufacturer (2020-2025)
    3.3 Global Dendritic Cell Vaccine Average Price by Manufacturer (2020-2025)
    3.4 Market Share Analysis (2024)
        3.4.1 Producer Shipments of Dendritic Cell Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2024
        3.4.2 Top 3 Dendritic Cell Vaccine Manufacturer Market Share in 2024
        3.4.3 Top 6 Dendritic Cell Vaccine Manufacturer Market Share in 2024
    3.5 Dendritic Cell Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Dendritic Cell Vaccine Market: Region Footprint
        3.5.2 Dendritic Cell Vaccine Market: Company Product Type Footprint
        3.5.3 Dendritic Cell Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Dendritic Cell Vaccine Market Size by Region
        4.1.1 Global Dendritic Cell Vaccine Sales Quantity by Region (2020-2031)
        4.1.2 Global Dendritic Cell Vaccine Consumption Value by Region (2020-2031)
        4.1.3 Global Dendritic Cell Vaccine Average Price by Region (2020-2031)
    4.2 North America Dendritic Cell Vaccine Consumption Value (2020-2031)
    4.3 Europe Dendritic Cell Vaccine Consumption Value (2020-2031)
    4.4 Asia-Pacific Dendritic Cell Vaccine Consumption Value (2020-2031)
    4.5 South America Dendritic Cell Vaccine Consumption Value (2020-2031)
    4.6 Middle East & Africa Dendritic Cell Vaccine Consumption Value (2020-2031)

5 Market Segment by Type
    5.1 Global Dendritic Cell Vaccine Sales Quantity by Type (2020-2031)
    5.2 Global Dendritic Cell Vaccine Consumption Value by Type (2020-2031)
    5.3 Global Dendritic Cell Vaccine Average Price by Type (2020-2031)

6 Market Segment by Application
    6.1 Global Dendritic Cell Vaccine Sales Quantity by Application (2020-2031)
    6.2 Global Dendritic Cell Vaccine Consumption Value by Application (2020-2031)
    6.3 Global Dendritic Cell Vaccine Average Price by Application (2020-2031)

7 North America
    7.1 North America Dendritic Cell Vaccine Sales Quantity by Type (2020-2031)
    7.2 North America Dendritic Cell Vaccine Sales Quantity by Application (2020-2031)
    7.3 North America Dendritic Cell Vaccine Market Size by Country
        7.3.1 North America Dendritic Cell Vaccine Sales Quantity by Country (2020-2031)
        7.3.2 North America Dendritic Cell Vaccine Consumption Value by Country (2020-2031)
        7.3.3 United States Market Size and Forecast (2020-2031)
        7.3.4 Canada Market Size and Forecast (2020-2031)
        7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe
    8.1 Europe Dendritic Cell Vaccine Sales Quantity by Type (2020-2031)
    8.2 Europe Dendritic Cell Vaccine Sales Quantity by Application (2020-2031)
    8.3 Europe Dendritic Cell Vaccine Market Size by Country
        8.3.1 Europe Dendritic Cell Vaccine Sales Quantity by Country (2020-2031)
        8.3.2 Europe Dendritic Cell Vaccine Consumption Value by Country (2020-2031)
        8.3.3 Germany Market Size and Forecast (2020-2031)
        8.3.4 France Market Size and Forecast (2020-2031)
        8.3.5 United Kingdom Market Size and Forecast (2020-2031)
        8.3.6 Russia Market Size and Forecast (2020-2031)
        8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific
    9.1 Asia-Pacific Dendritic Cell Vaccine Sales Quantity by Type (2020-2031)
    9.2 Asia-Pacific Dendritic Cell Vaccine Sales Quantity by Application (2020-2031)
    9.3 Asia-Pacific Dendritic Cell Vaccine Market Size by Region
        9.3.1 Asia-Pacific Dendritic Cell Vaccine Sales Quantity by Region (2020-2031)
        9.3.2 Asia-Pacific Dendritic Cell Vaccine Consumption Value by Region (2020-2031)
        9.3.3 China Market Size and Forecast (2020-2031)
        9.3.4 Japan Market Size and Forecast (2020-2031)
        9.3.5 South Korea Market Size and Forecast (2020-2031)
        9.3.6 India Market Size and Forecast (2020-2031)
        9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
        9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America
    10.1 South America Dendritic Cell Vaccine Sales Quantity by Type (2020-2031)
    10.2 South America Dendritic Cell Vaccine Sales Quantity by Application (2020-2031)
    10.3 South America Dendritic Cell Vaccine Market Size by Country
        10.3.1 South America Dendritic Cell Vaccine Sales Quantity by Country (2020-2031)
        10.3.2 South America Dendritic Cell Vaccine Consumption Value by Country (2020-2031)
        10.3.3 Brazil Market Size and Forecast (2020-2031)
        10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa
    11.1 Middle East & Africa Dendritic Cell Vaccine Sales Quantity by Type (2020-2031)
    11.2 Middle East & Africa Dendritic Cell Vaccine Sales Quantity by Application (2020-2031)
    11.3 Middle East & Africa Dendritic Cell Vaccine Market Size by Country
        11.3.1 Middle East & Africa Dendritic Cell Vaccine Sales Quantity by Country (2020-2031)
        11.3.2 Middle East & Africa Dendritic Cell Vaccine Consumption Value by Country (2020-2031)
        11.3.3 Turkey Market Size and Forecast (2020-2031)
        11.3.4 Egypt Market Size and Forecast (2020-2031)
        11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
        11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics
    12.1 Dendritic Cell Vaccine Market Drivers
    12.2 Dendritic Cell Vaccine Market Restraints
    12.3 Dendritic Cell Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Dendritic Cell Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Dendritic Cell Vaccine
    13.3 Dendritic Cell Vaccine Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Dendritic Cell Vaccine Typical Distributors
    14.3 Dendritic Cell Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Dendritic Cell Vaccine Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 2. Global Dendritic Cell Vaccine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 3. 3M Basic Information, Manufacturing Base and Competitors
 Table 4. 3M Major Business
 Table 5. 3M Dendritic Cell Vaccine Product and Services
 Table 6. 3M Dendritic Cell Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 7. 3M Recent Developments/Updates
 Table 8. Activarti Basic Information, Manufacturing Base and Competitors
 Table 9. Activarti Major Business
 Table 10. Activarti Dendritic Cell Vaccine Product and Services
 Table 11. Activarti Dendritic Cell Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 12. Activarti Recent Developments/Updates
 Table 13. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 14. Argos Therapeutics Major Business
 Table 15. Argos Therapeutics Dendritic Cell Vaccine Product and Services
 Table 16. Argos Therapeutics Dendritic Cell Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 17. Argos Therapeutics Recent Developments/Updates
 Table 18. Batavia Bioservices Basic Information, Manufacturing Base and Competitors
 Table 19. Batavia Bioservices Major Business
 Table 20. Batavia Bioservices Dendritic Cell Vaccine Product and Services
 Table 21. Batavia Bioservices Dendritic Cell Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 22. Batavia Bioservices Recent Developments/Updates
 Table 23. Bellicum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 24. Bellicum Pharmaceuticals Major Business
 Table 25. Bellicum Pharmaceuticals Dendritic Cell Vaccine Product and Services
 Table 26. Bellicum Pharmaceuticals Dendritic Cell Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 27. Bellicum Pharmaceuticals Recent Developments/Updates
 Table 28. Creagene Basic Information, Manufacturing Base and Competitors
 Table 29. Creagene Major Business
 Table 30. Creagene Dendritic Cell Vaccine Product and Services
 Table 31. Creagene Dendritic Cell Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 32. Creagene Recent Developments/Updates
 Table 33. DanDrit Biotech Basic Information, Manufacturing Base and Competitors
 Table 34. DanDrit Biotech Major Business
 Table 35. DanDrit Biotech Dendritic Cell Vaccine Product and Services
 Table 36. DanDrit Biotech Dendritic Cell Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 37. DanDrit Biotech Recent Developments/Updates
 Table 38. DCPrime Basic Information, Manufacturing Base and Competitors
 Table 39. DCPrime Major Business
 Table 40. DCPrime Dendritic Cell Vaccine Product and Services
 Table 41. DCPrime Dendritic Cell Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 42. DCPrime Recent Developments/Updates
 Table 43. Sanpower Corporation (Dendreon Corporation) Basic Information, Manufacturing Base and Competitors
 Table 44. Sanpower Corporation (Dendreon Corporation) Major Business
 Table 45. Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Product and Services
 Table 46. Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 47. Sanpower Corporation (Dendreon Corporation) Recent Developments/Updates
 Table 48. Elios Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 49. Elios Therapeutics Major Business
 Table 50. Elios Therapeutics Dendritic Cell Vaccine Product and Services
 Table 51. Elios Therapeutics Dendritic Cell Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 52. Elios Therapeutics Recent Developments/Updates
 Table 53. ImmunoCellular Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 54. ImmunoCellular Therapeutics Major Business
 Table 55. ImmunoCellular Therapeutics Dendritic Cell Vaccine Product and Services
 Table 56. ImmunoCellular Therapeutics Dendritic Cell Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 57. ImmunoCellular Therapeutics Recent Developments/Updates
 Table 58. Immunicum Basic Information, Manufacturing Base and Competitors
 Table 59. Immunicum Major Business
 Table 60. Immunicum Dendritic Cell Vaccine Product and Services
 Table 61. Immunicum Dendritic Cell Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 62. Immunicum Recent Developments/Updates
 Table 63. Kiromic Basic Information, Manufacturing Base and Competitors
 Table 64. Kiromic Major Business
 Table 65. Kiromic Dendritic Cell Vaccine Product and Services
 Table 66. Kiromic Dendritic Cell Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 67. Kiromic Recent Developments/Updates
 Table 68. Medigene Basic Information, Manufacturing Base and Competitors
 Table 69. Medigene Major Business
 Table 70. Medigene Dendritic Cell Vaccine Product and Services
 Table 71. Medigene Dendritic Cell Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 72. Medigene Recent Developments/Updates
 Table 73. Merck & Co. Basic Information, Manufacturing Base and Competitors
 Table 74. Merck & Co. Major Business
 Table 75. Merck & Co. Dendritic Cell Vaccine Product and Services
 Table 76. Merck & Co. Dendritic Cell Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 77. Merck & Co. Recent Developments/Updates
 Table 78. Global Dendritic Cell Vaccine Sales Quantity by Manufacturer (2020-2025) & (K Units)
 Table 79. Global Dendritic Cell Vaccine Revenue by Manufacturer (2020-2025) & (USD Million)
 Table 80. Global Dendritic Cell Vaccine Average Price by Manufacturer (2020-2025) & (US$/Unit)
 Table 81. Market Position of Manufacturers in Dendritic Cell Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
 Table 82. Head Office and Dendritic Cell Vaccine Production Site of Key Manufacturer
 Table 83. Dendritic Cell Vaccine Market: Company Product Type Footprint
 Table 84. Dendritic Cell Vaccine Market: Company Product Application Footprint
 Table 85. Dendritic Cell Vaccine New Market Entrants and Barriers to Market Entry
 Table 86. Dendritic Cell Vaccine Mergers, Acquisition, Agreements, and Collaborations
 Table 87. Global Dendritic Cell Vaccine Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
 Table 88. Global Dendritic Cell Vaccine Sales Quantity by Region (2020-2025) & (K Units)
 Table 89. Global Dendritic Cell Vaccine Sales Quantity by Region (2026-2031) & (K Units)
 Table 90. Global Dendritic Cell Vaccine Consumption Value by Region (2020-2025) & (USD Million)
 Table 91. Global Dendritic Cell Vaccine Consumption Value by Region (2026-2031) & (USD Million)
 Table 92. Global Dendritic Cell Vaccine Average Price by Region (2020-2025) & (US$/Unit)
 Table 93. Global Dendritic Cell Vaccine Average Price by Region (2026-2031) & (US$/Unit)
 Table 94. Global Dendritic Cell Vaccine Sales Quantity by Type (2020-2025) & (K Units)
 Table 95. Global Dendritic Cell Vaccine Sales Quantity by Type (2026-2031) & (K Units)
 Table 96. Global Dendritic Cell Vaccine Consumption Value by Type (2020-2025) & (USD Million)
 Table 97. Global Dendritic Cell Vaccine Consumption Value by Type (2026-2031) & (USD Million)
 Table 98. Global Dendritic Cell Vaccine Average Price by Type (2020-2025) & (US$/Unit)
 Table 99. Global Dendritic Cell Vaccine Average Price by Type (2026-2031) & (US$/Unit)
 Table 100. Global Dendritic Cell Vaccine Sales Quantity by Application (2020-2025) & (K Units)
 Table 101. Global Dendritic Cell Vaccine Sales Quantity by Application (2026-2031) & (K Units)
 Table 102. Global Dendritic Cell Vaccine Consumption Value by Application (2020-2025) & (USD Million)
 Table 103. Global Dendritic Cell Vaccine Consumption Value by Application (2026-2031) & (USD Million)
 Table 104. Global Dendritic Cell Vaccine Average Price by Application (2020-2025) & (US$/Unit)
 Table 105. Global Dendritic Cell Vaccine Average Price by Application (2026-2031) & (US$/Unit)
 Table 106. North America Dendritic Cell Vaccine Sales Quantity by Type (2020-2025) & (K Units)
 Table 107. North America Dendritic Cell Vaccine Sales Quantity by Type (2026-2031) & (K Units)
 Table 108. North America Dendritic Cell Vaccine Sales Quantity by Application (2020-2025) & (K Units)
 Table 109. North America Dendritic Cell Vaccine Sales Quantity by Application (2026-2031) & (K Units)
 Table 110. North America Dendritic Cell Vaccine Sales Quantity by Country (2020-2025) & (K Units)
 Table 111. North America Dendritic Cell Vaccine Sales Quantity by Country (2026-2031) & (K Units)
 Table 112. North America Dendritic Cell Vaccine Consumption Value by Country (2020-2025) & (USD Million)
 Table 113. North America Dendritic Cell Vaccine Consumption Value by Country (2026-2031) & (USD Million)
 Table 114. Europe Dendritic Cell Vaccine Sales Quantity by Type (2020-2025) & (K Units)
 Table 115. Europe Dendritic Cell Vaccine Sales Quantity by Type (2026-2031) & (K Units)
 Table 116. Europe Dendritic Cell Vaccine Sales Quantity by Application (2020-2025) & (K Units)
 Table 117. Europe Dendritic Cell Vaccine Sales Quantity by Application (2026-2031) & (K Units)
 Table 118. Europe Dendritic Cell Vaccine Sales Quantity by Country (2020-2025) & (K Units)
 Table 119. Europe Dendritic Cell Vaccine Sales Quantity by Country (2026-2031) & (K Units)
 Table 120. Europe Dendritic Cell Vaccine Consumption Value by Country (2020-2025) & (USD Million)
 Table 121. Europe Dendritic Cell Vaccine Consumption Value by Country (2026-2031) & (USD Million)
 Table 122. Asia-Pacific Dendritic Cell Vaccine Sales Quantity by Type (2020-2025) & (K Units)
 Table 123. Asia-Pacific Dendritic Cell Vaccine Sales Quantity by Type (2026-2031) & (K Units)
 Table 124. Asia-Pacific Dendritic Cell Vaccine Sales Quantity by Application (2020-2025) & (K Units)
 Table 125. Asia-Pacific Dendritic Cell Vaccine Sales Quantity by Application (2026-2031) & (K Units)
 Table 126. Asia-Pacific Dendritic Cell Vaccine Sales Quantity by Region (2020-2025) & (K Units)
 Table 127. Asia-Pacific Dendritic Cell Vaccine Sales Quantity by Region (2026-2031) & (K Units)
 Table 128. Asia-Pacific Dendritic Cell Vaccine Consumption Value by Region (2020-2025) & (USD Million)
 Table 129. Asia-Pacific Dendritic Cell Vaccine Consumption Value by Region (2026-2031) & (USD Million)
 Table 130. South America Dendritic Cell Vaccine Sales Quantity by Type (2020-2025) & (K Units)
 Table 131. South America Dendritic Cell Vaccine Sales Quantity by Type (2026-2031) & (K Units)
 Table 132. South America Dendritic Cell Vaccine Sales Quantity by Application (2020-2025) & (K Units)
 Table 133. South America Dendritic Cell Vaccine Sales Quantity by Application (2026-2031) & (K Units)
 Table 134. South America Dendritic Cell Vaccine Sales Quantity by Country (2020-2025) & (K Units)
 Table 135. South America Dendritic Cell Vaccine Sales Quantity by Country (2026-2031) & (K Units)
 Table 136. South America Dendritic Cell Vaccine Consumption Value by Country (2020-2025) & (USD Million)
 Table 137. South America Dendritic Cell Vaccine Consumption Value by Country (2026-2031) & (USD Million)
 Table 138. Middle East & Africa Dendritic Cell Vaccine Sales Quantity by Type (2020-2025) & (K Units)
 Table 139. Middle East & Africa Dendritic Cell Vaccine Sales Quantity by Type (2026-2031) & (K Units)
 Table 140. Middle East & Africa Dendritic Cell Vaccine Sales Quantity by Application (2020-2025) & (K Units)
 Table 141. Middle East & Africa Dendritic Cell Vaccine Sales Quantity by Application (2026-2031) & (K Units)
 Table 142. Middle East & Africa Dendritic Cell Vaccine Sales Quantity by Country (2020-2025) & (K Units)
 Table 143. Middle East & Africa Dendritic Cell Vaccine Sales Quantity by Country (2026-2031) & (K Units)
 Table 144. Middle East & Africa Dendritic Cell Vaccine Consumption Value by Country (2020-2025) & (USD Million)
 Table 145. Middle East & Africa Dendritic Cell Vaccine Consumption Value by Country (2026-2031) & (USD Million)
 Table 146. Dendritic Cell Vaccine Raw Material
 Table 147. Key Manufacturers of Dendritic Cell Vaccine Raw Materials
 Table 148. Dendritic Cell Vaccine Typical Distributors
 Table 149. Dendritic Cell Vaccine Typical Customers


List of Figures
 Figure 1. Dendritic Cell Vaccine Picture
 Figure 2. Global Dendritic Cell Vaccine Revenue by Type, (USD Million), 2020 & 2024 & 2031
 Figure 3. Global Dendritic Cell Vaccine Revenue Market Share by Type in 2024
 Figure 4. Non-Targeted Examples
 Figure 5. Target Examples
 Figure 6. Global Dendritic Cell Vaccine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 7. Global Dendritic Cell Vaccine Revenue Market Share by Application in 2024
 Figure 8. Covid-19 Examples
 Figure 9. Cancer Examples
 Figure 10. Others Examples
 Figure 11. Global Dendritic Cell Vaccine Consumption Value, (USD Million): 2020 & 2024 & 2031
 Figure 12. Global Dendritic Cell Vaccine Consumption Value and Forecast (2020-2031) & (USD Million)
 Figure 13. Global Dendritic Cell Vaccine Sales Quantity (2020-2031) & (K Units)
 Figure 14. Global Dendritic Cell Vaccine Price (2020-2031) & (US$/Unit)
 Figure 15. Global Dendritic Cell Vaccine Sales Quantity Market Share by Manufacturer in 2024
 Figure 16. Global Dendritic Cell Vaccine Revenue Market Share by Manufacturer in 2024
 Figure 17. Producer Shipments of Dendritic Cell Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2024
 Figure 18. Top 3 Dendritic Cell Vaccine Manufacturer (Revenue) Market Share in 2024
 Figure 19. Top 6 Dendritic Cell Vaccine Manufacturer (Revenue) Market Share in 2024
 Figure 20. Global Dendritic Cell Vaccine Sales Quantity Market Share by Region (2020-2031)
 Figure 21. Global Dendritic Cell Vaccine Consumption Value Market Share by Region (2020-2031)
 Figure 22. North America Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 23. Europe Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 24. Asia-Pacific Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 25. South America Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 26. Middle East & Africa Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 27. Global Dendritic Cell Vaccine Sales Quantity Market Share by Type (2020-2031)
 Figure 28. Global Dendritic Cell Vaccine Consumption Value Market Share by Type (2020-2031)
 Figure 29. Global Dendritic Cell Vaccine Average Price by Type (2020-2031) & (US$/Unit)
 Figure 30. Global Dendritic Cell Vaccine Sales Quantity Market Share by Application (2020-2031)
 Figure 31. Global Dendritic Cell Vaccine Revenue Market Share by Application (2020-2031)
 Figure 32. Global Dendritic Cell Vaccine Average Price by Application (2020-2031) & (US$/Unit)
 Figure 33. North America Dendritic Cell Vaccine Sales Quantity Market Share by Type (2020-2031)
 Figure 34. North America Dendritic Cell Vaccine Sales Quantity Market Share by Application (2020-2031)
 Figure 35. North America Dendritic Cell Vaccine Sales Quantity Market Share by Country (2020-2031)
 Figure 36. North America Dendritic Cell Vaccine Consumption Value Market Share by Country (2020-2031)
 Figure 37. United States Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 38. Canada Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 39. Mexico Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 40. Europe Dendritic Cell Vaccine Sales Quantity Market Share by Type (2020-2031)
 Figure 41. Europe Dendritic Cell Vaccine Sales Quantity Market Share by Application (2020-2031)
 Figure 42. Europe Dendritic Cell Vaccine Sales Quantity Market Share by Country (2020-2031)
 Figure 43. Europe Dendritic Cell Vaccine Consumption Value Market Share by Country (2020-2031)
 Figure 44. Germany Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 45. France Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 46. United Kingdom Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 47. Russia Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 48. Italy Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 49. Asia-Pacific Dendritic Cell Vaccine Sales Quantity Market Share by Type (2020-2031)
 Figure 50. Asia-Pacific Dendritic Cell Vaccine Sales Quantity Market Share by Application (2020-2031)
 Figure 51. Asia-Pacific Dendritic Cell Vaccine Sales Quantity Market Share by Region (2020-2031)
 Figure 52. Asia-Pacific Dendritic Cell Vaccine Consumption Value Market Share by Region (2020-2031)
 Figure 53. China Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 54. Japan Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 55. South Korea Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 56. India Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 57. Southeast Asia Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 58. Australia Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 59. South America Dendritic Cell Vaccine Sales Quantity Market Share by Type (2020-2031)
 Figure 60. South America Dendritic Cell Vaccine Sales Quantity Market Share by Application (2020-2031)
 Figure 61. South America Dendritic Cell Vaccine Sales Quantity Market Share by Country (2020-2031)
 Figure 62. South America Dendritic Cell Vaccine Consumption Value Market Share by Country (2020-2031)
 Figure 63. Brazil Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 64. Argentina Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 65. Middle East & Africa Dendritic Cell Vaccine Sales Quantity Market Share by Type (2020-2031)
 Figure 66. Middle East & Africa Dendritic Cell Vaccine Sales Quantity Market Share by Application (2020-2031)
 Figure 67. Middle East & Africa Dendritic Cell Vaccine Sales Quantity Market Share by Country (2020-2031)
 Figure 68. Middle East & Africa Dendritic Cell Vaccine Consumption Value Market Share by Country (2020-2031)
 Figure 69. Turkey Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 70. Egypt Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 71. Saudi Arabia Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 72. South Africa Dendritic Cell Vaccine Consumption Value (2020-2031) & (USD Million)
 Figure 73. Dendritic Cell Vaccine Market Drivers
 Figure 74. Dendritic Cell Vaccine Market Restraints
 Figure 75. Dendritic Cell Vaccine Market Trends
 Figure 76. Porters Five Forces Analysis
 Figure 77. Manufacturing Cost Structure Analysis of Dendritic Cell Vaccine in 2024
 Figure 78. Manufacturing Process Analysis of Dendritic Cell Vaccine
 Figure 79. Dendritic Cell Vaccine Industrial Chain
 Figure 80. Sales Channel: Direct to End-User vs Distributors
 Figure 81. Direct Channel Pros & Cons
 Figure 82. Indirect Channel Pros & Cons
 Figure 83. Methodology
 Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

3M
Activarti
Argos Therapeutics
Batavia Bioservices
Bellicum Pharmaceuticals
Creagene
DanDrit Biotech
DCPrime
Sanpower Corporation (Dendreon Corporation)
Elios Therapeutics
ImmunoCellular Therapeutics
Immunicum
Kiromic
Medigene
Merck & Co.

Related Reports

Global Dendritic Cell Vaccine Supply, Demand and Key Producers, 2023-2029

Global Dendritic Cell Vaccine Supply, Demand and Key Producers, 2023-2029

date 06 Sep 2023

date Pharma & Healthcare

The global Dendritic Cell Vaccine market size is expected to reach $ 80 million by 2029, rising at a market growth of 3.0% CAGR during the forecast period (2023-2029).

Global Dendritic Cell Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Dendritic Cell Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 06 Sep 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Dendritic Cell Vaccine market size was valued at USD 65 million in 2022 and is forecast to a readjusted size of USD 80 million by 2029 with a CAGR of 3.0% during review period.

Global Dendritic Cell Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Dendritic Cell Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Dendritic Cell Vaccine market size was valued at USD 65 million in 2023 and is forecast to a readjusted size of USD 80 million by 2030 with a CAGR of 3.0% during review period.

Product Tags

Dendritic Cell Vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>